Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $62.50 short put and a strike $57.50 long put offers a potential 5.93% return on risk over the next 3 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $62.50 by expiration. The full premium credit of $0.28 would be kept by the premium seller. The risk of $4.72 would be incurred if the stock dropped below the $57.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 60.8 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Abbott Declares 378th Consecutive Quarterly Dividend
Fri, 08 Jun 2018 14:15:00 +0000
ABBOTT PARK, Ill., June 8, 2018 /PRNewswire/ — The board of directors of Abbott (ABT) today declared a quarterly common dividend of 28 cents per share. This marks the 378th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2018, to shareholders of record at the close of business on July 13, 2018.
Bio-Rad Banks on Solid Global Scenario, Competition Rife
Fri, 08 Jun 2018 13:14:01 +0000
Bio-Rad (BIO) delivers robust performance, primarily in North America, China and the Asia-Pacific region.
See what the IHS Markit Score report has to say about Abbott Laboratories.
Fri, 08 Jun 2018 12:01:10 +0000
Abbott Laboratories NYSE:ABT
The brain stimulator communicator: Tears of joy are just a happy byproduct in manager’s line of work
Wed, 06 Jun 2018 22:09:40 +0000
Abbott Laboratories' Lisa Distenfield is tasked with communicating the intricacies of the latest groundbreaking neuro technology.
For investors looking for a summer fling, one sector could fit the bill
Tue, 05 Jun 2018 17:22:00 +0000
Health care has been the best-performing sector between June and August since 1990, according to a new Oppenheimer note. But if the sector rallied this year, not all names in the group will participate, says the firm’s top technician.
Also on Market Tamer…
Follow Us on Facebook